Deliver Life Sciences is a specialty producer and organizer of the conference, workshop, training together with tailored solutions to serve the growing biomedical industry in Asia. Through looking into the current trends of...
The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry's leading role in developing vaccines against COVID-19 in response to the global pandemic. This year's conference will reflect on how the industry has adapted and pl...
Similarly, RNAi drugs such as short hairpin RNAs (shRNAs) have been employed in RNA therapeutics. The mechanism of shRNA drugs is based on the repression of target gene expression through complementary base pairing between the shRNA and its target mRNA. Embedding shRNAs into miRNA backbones ...
The Second International Conference on RNA Nanotechnology and TherapeuticsLeontis, NSweeney, BHaque, FGuo, P X
et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat. Commun. 13, 1536 (2022). Article CAS PubMed PubMed Central Google Scholar Sun, L. et al. RNA structure maps across mammalian cellular compartments. Nat. Struct. Mol. Biol. 26,...
Define messenger RNA. messenger RNA synonyms, messenger RNA pronunciation, messenger RNA translation, English dictionary definition of messenger RNA. n. Abbr. mRNA The form of RNA that mediates the transfer of genetic information from the cell nucleus to
Topics of interest will include, but not limited to: -Regulation of non-coding RNAs -Targets and regulatory functions of non-coding RNAs -Epigenetics and non-coding RNAs -Biological functions of non-coding RNAs -Non-coding RNAs as biomarkers -Non-coding RNA-based therapeutics -Prognostic value ...
近日,MiNA Therapeutics公司公布了其针对胎儿血红蛋白(HbF)的主要激活RNA(RNAa)产品的新临床前数据。临床前体内研究结果表明,MiNA公司的RNAa治疗药物可被递送到骨髓中的红细胞祖细胞,并且药物水平对治疗β-血红蛋白病具有临床意义。 这些来自动物模型的数据证实了MiNA公司针对HbF的RNAa治疗药物能够高效地分布到红细胞祖细...
changing the proportions of siRNA triggers against HBs and HBx according to clinical virus parameters of patients may help improve therapeutic outcome. Next, while the rAAV-HBV1.3 model is the most studied model of chronic HBV infection for investigating the effects of anti-HBV therapeutics, it ...
No. 62/314,322, by Dean Falb, et al., entitled Microorganisms Programmed to Produce Immune Modulators and Anti-Cancer Therapeutics in Tumor Cells, filed Mar. 28, 2016. Van Der Jeught, et al., “Targeting the tumor microenvironment to enhance antitumor immune responses” Oncotarget, 6(3):...